UC - ULCERATIVE COLITIS
Clinical trials for UC - ULCERATIVE COLITIS explained in plain language.
Never miss a new study
Get alerted when new UC - ULCERATIVE COLITIS trials appear
Sign up with your email to follow new studies for UC - ULCERATIVE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could spare ulcerative colitis patients from emergency surgery
Disease control Not yet recruitingThis study tests whether the oral medication upadacitinib can safely treat adults hospitalized with a severe flare of ulcerative colitis. Researchers want to see if it reduces the need for emergency surgery or rescue treatments within the first two weeks. Fifty participants will …
Matched conditions: UC - ULCERATIVE COLITIS
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New ulcerative colitis drug enters first human safety tests
Disease control Not yet recruitingThis early-stage study tests the safety of a new drug called LYNC-101 in 50 healthy adults. The drug is being developed to control ulcerative colitis, a chronic bowel disease. Participants receive one or three intravenous infusions and are monitored for side effects. This study d…
Matched conditions: UC - ULCERATIVE COLITIS
Phase: PHASE1 • Sponsor: LyncBio Therapeutics Co., Ltd. • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC